New Jersey Better Educational Savings Trust Abb Vie Inc. Transaction History

New Jersey Better Educational Savings Trust

$50 Million
Q2 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$107.43 - $135.93 $49,417 - $62,527	-460 Reduced 14.15%	2,790 $378,000
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $92,070 - $101,358	-900 Reduced 21.69%	3,250 $352,000
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $185,287 - $250,158	-2,302 Reduced 35.68%	4,150 $445,000
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $69,848 - $93,467	952 Added 17.31%	6,452 $633,000
Q2 2019 Jul 09, 2019	BUY	$65.7 - $83.98 $32,850 - $41,990	500 Added 10.0%	5,500 $400,000
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $192,850 - $226,975	-2,500 Reduced 33.33%	5,000 $403,000
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $44,455 - $49,420	-500 Reduced 6.25%	7,500 $709,000
Q2 2018 Jul 30, 2018	BUY	$89.78 - $106.23 $89,780 - $106,230	1,000 Added 14.29%	8,000 $741,000
Q1 2018 Apr 30, 2018	BUY	$92.01 - $123.21 $184,020 - $246,420	2,000 Added 40.0%	7,000 $663,000
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $89,560 - $98,210	-1,000 Reduced 16.67%	5,000 $484,000
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $419,099 - $535,320	6,000	6,000 $533,000

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$33.7 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$26.9 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$15.4 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

53.6M
Shares

$10.6 Billion
0.81% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$7.62 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Jersey Better Educational Savings Trust, based on Form 13F filings with the SEC.

News

Stay updated on New Jersey Better Educational Savings Trust with notifications on news.

Account